Publications

Title

Author

Year

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23-24 March 2015.

Modjarrad, K; Giersing, B; Kaslow, DC; SMITH, PG; Moorthy, VS; WHO RSV Vaccine Consultation Expert Group,;

2015

Vaccine, (2015).34 2 10.1016/j.vaccine.2015.05.093.

The impact of maternal infection with Mycobacterium tuberculosis on the infant response to bacille Calmette-Guérin immunization.

MAWA, PA; NKURUNUNGI, G; EGESA, M; WEBB, EL; SMITH, SG; Kizindo, R; Akello, M; Lule, SA; Muwanga, M; DOCKRELL, HM; COSE, S; ELLIOTT, AM;

2015

Philosophical transactions of the Royal Society of London Series B, Biological sciences, (2015).370 1671 10.1098/rstb.2014.0137.

Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers.

Feazel, LM; Santorico, SA; Robertson, CE; Bashraheil, M; SCOTT, JA G; Frank, DN; Hammitt, LL;

2015

PloS one, (2015).10 6 10.1371/journal.pone.0128064.

10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine (PHiD-CV) induces memory B cell responses in healthy Kenyan toddlers.

Muema, DM; Nduati, EW; Uyoga, M; Bashraheil, M; SCOTT, JA G; Hammitt, LL; Urban, BC;

2015

Clinical and experimental immunology, (2015).181 2 10.1111/cei.12637.

The Potential for Reducing the Number of Pneumococcal Conjugate Vaccine Doses While Sustaining Herd Immunity in High-Income Countries.

FLASCHE, S; VAN HOEK, AJ; Goldblatt, D; EDMUNDS, WJ; O'Brien, KL; SCOTT, JA G; MILLER, E;

2015

PLoS medicine, (2015).12 6 10.1371/journal.pmed.1001839.

Sequential chemoimmunotherapy of experimental visceral leishmaniasis using a single low dose of liposomal amphotericin B and a novel DNA vaccine candidate.

SEIFERT, K; Juhls, C; Salguero, FJ; CROFT, SL;

2015

Antimicrobial agents and chemotherapy, (2015).59 9 10.1128/AAC.00273-15.

Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment.

TIENTCHEU, LD; Maertzdorf, J; Weiner, J; ADETIFA, IM; Mollenkopf, H-J; SUTHERLAND, JS; Donkor, S; KAMPMANN, B; Kaufmann, SH E; DOCKRELL, HM; Ota, MO;

2015

Genes and immunity, (2015).16 5 10.1038/gene.2015.21.

Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.

Le, P; GRIFFITHS, UK; Anh, DD; Franzini, L; Chan, W; Swint, JM;

2015

Vaccine, (2015).33 36 10.1016/j.vaccine.2015.05.050.

Consensus on the development of vaccines against naturally acquired melioidosis.

Limmathurotsakul, D; Funnell, SG P; Torres, AG; Morici, LA; Brett, PJ; Dunachie, S; Atkins, T; Altmann, DM; BANCROFT, G; PEACOCK, SJ; Steering Group on Melioidosis Vaccine Development,;

2015

Emerging infectious diseases, (2015).21 6 10.3201/eid2106.141480.

Thirty years of vaccination in Vietnam: Impact and cost-effectiveness of the national Expanded Programme on Immunization.

JIT, M; Dang, TT H; Friberg, I; Hoang, VM; Pham Huy, TK; Walker, N; Nguyen, VC; Tran, ND; Toda, K; Hutubessy, R; Fox, K; Nguyen, TH;

2015

Vaccine, (2015).33 Sup Suppl 10.1016/j.vaccine.2014.12.017.